STING1 and neoplasm: This synergistic treatment achieved a significant improvement of tumor response and survival benefit in mice, which attributed to the promotion of imDCs recruitment and maturation in tumor tissue, the intracellular activation of cGAS/STING/IFN-I signaling pathway, and the subsequently enhanced antitumor immunity.